Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1NET 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Lung Neoplasms 12Small Cell Lung Carcinoma 4Carcinoma, Renal Cell 4Triple Negative Breast Neoplasms 2Neuroendocrine Tumors 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Mesothelioma 2Thymoma 1Somatostatinoma 1Recurrence 1Pheochromocytoma 1Ovarian Neoplasms 1Multiple Myeloma 1Melanoma 1Insulinoma 1Hereditary Sensory and Autonomic Neuropathies 1Glucagonoma 1Gastrointestinal Neoplasms 1Gastrinoma 1Colorectal Neoplasms 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Carcinoma, Large Cell 1Carcinoma, Islet Cell 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Docetaxel 3Carboplatin 3motexafin gadolinium 2figitumumab 2cemiplimab 2brigatinib 2alpha-2'-deoxythioguanosine 2Paclitaxel 2vandetanib 1temoporfin 1tanespimycin 1Vinorelbine 1Temozolomide 1Radiotherapy 1Radiosurgery 1Pemetrexed 1Oxaliplatin 1Gemcitabine 1Everolimus 1Erlotinib Hydrochloride 1Crizotinib 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Large Cell × Everolimus × Thoracic × Clear all
NCT01317615 2016-03-30

RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation

Novartis

Phase 4 Completed
49 enrolled 11 charts
EndocrineNETThoracic

Lung Neoplasms, Carcinoma, Large Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡